News
05-05-2014, 03:51 PM
The $260 million Women's Health Initiative (WHI) Estrogen Plus Progestin (E+P) clinical trial yielded a huge economic return on investment, according to a modeling study being published in Annals...
More... (http://www.medicalnewstoday.com/releases/276225.php)
More... (http://www.medicalnewstoday.com/releases/276225.php)